Naung Latt Htun: High Clinical Suspicion in Acquired Hemophilia A is Essential
Naung Latt Htun, Internal Medicine Doctor at Ministry of Health Brunei Darussalam, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share that our latest case report has been published in Cureus Journal of Medical Science!
Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
In this paper, we present two rare and clinically challenging cases of AHA – an uncommon but potentially life-threatening autoimmune bleeding disorder caused by factor VIII inhibitors.
Key highlights:
- AHA can present with unexplained bleeding and isolated prolonged aPTT
- Underlying causes can be diverse – including malignancy, autoimmune conditions, and infections
- Coexistence with antiphospholipid antibodies creates a complex paradox of bleeding vs thrombosis
- Early recognition and a dual management approach (bleeding control plus inhibitor eradication) are critical
These cases emphasize the importance of maintaining a high index of suspicion when evaluating unexplained bleeding, especially in patients with comorbid conditions.
Proud to have worked with an excellent team on this publication!”
Title: Acquired Hemophilia A (AHA) Associated With Malignancy and Antiphospholipid Antibodies: Two Case Reports With Distinct Etiologies
Authors: Naung Latt Htun, Hsan Theingi Win, Mohammad Abdullah, Hnin Kay Khine Oo, Dilip Thottacherry
Read the Full Article on Cureus Journal of Medical Science

Stay updated on all scientific advances with Hemostasis Today.
-
Jul 16, 2026, 19:53Louise St. Germain Bannon: The End of Congress, the Beginning of New Collaborations
-
Jul 16, 2026, 19:18Steve Humphreys: Learning From the Leading Experts at ISTH 2026
-
Jul 16, 2026, 19:02Kellie Machlus: Where Science Meets Friendship at ISTH 2026
-
Jul 16, 2026, 18:51Aaron Paul Kithcart: When Clinical Research Comes Together at ISTH 2026
-
Jul 16, 2026, 18:40Sara Buonomo: Predicting Relapse in Immune-Mediated TTP at ISTH 2026
-
Jul 16, 2026, 18:28Tom McKinnon: The Conversations That Continue Beyond ISTH 2026
-
Jul 16, 2026, 15:17Denise Braendgaard: Turning ISTH 2026 Connections into Better Patient Care
-
Jul 16, 2026, 12:30Amihai Rottenstreich: Women’s Health and Multidisciplinary Care Lead ISTH 2026 Discussions
-
Jul 16, 2026, 12:19Floor Heubel-Moenen: Maastricht Team Highlights BDUC Research at ISTH 2026